Acute Pergolide Exposure Stiffens Engineered Valve Interstitial Cell Tissues and Reduces Contractility In Vitro

• Published in: Cardiovascular pathology Vol. 25; no. 4; pp. 316 - 324
• Main Authors: Capulli, Andrew K, MacQueen, Luke A, O'Connor, Blakely B, Dauth, Stephanie, Parker, Kevin Kit
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.07.2016
• Subjects: Animals; Aortic Valve - drug effects; Blotting, Western; Dopamine Agonists - toxicity; Drug Evaluation, Preclinical; Ergoline; Extracellular Matrix - drug effects; Extracellular Matrix - pathology; Fibroblasts - drug effects; Fibroblasts - pathology; In Vitro Techniques - methods; Muscle Contraction - drug effects; Pathology; Pergolide; Pergolide - toxicity; Serotonin agonist; Swine; Tissue Engineering - methods; Valve interstitial cells; Valvular heart disease; Vascular Stiffness; Ergoline; Serotonin Agonist; Valvular Heart Disease; Valve Interstitial Cells; Pergolide; Valvular heart disease; Valve interstitial cells; Serotonin agonist
• ISSN: 1054-8807; 1879-1336
• DOI: 10.1016/j.carpath.2016.04.004

Abstract Medications based on ergoline-derived dopamine and serotonin agonists are associated with off-target toxicities that include valvular heart disease (VHD). Reports of drug-induced VHD resulted in the withdrawal of appetite suppressants containing fenfluramine and phentermine from the U.S. market in 1997 and pergolide, a Parkinson's disease medication, in 2007. Recent evidence suggests that serotonin receptor activity affected by these medications modulates cardiac valve interstitial cell activation and subsequent valvular remodeling, which can lead to cardiac valve fibrosis and dysfunction similar to that seen in carcinoid heart disease. Failure to identify these risks prior to market, and continued use of similar drugs, reaffirms the need to improve preclinical evaluation of drug-induced VHD. Here, we present two complimentary assays to measure stiffness and contractile stresses generated by engineered valvular tissues in vitro . As a case study, we measured the effects of acute (24 h) pergolide exposure to engineered porcine aortic valve interstitial cell (AVIC) tissues. Pergolide exposure led to increased tissue stiffness but it decreased both basal and active contractile tone stresses generated by AVIC tissues. Pergolide exposure also disrupted AVIC tissue organization (i.e., tissue anisotropy), suggesting that the mechanical properties and contractile functionality of these tissues are governed by their ability to maintain their structure. We expect further use of these assays to identify off-target drug effects that alter the phenotypic balance of AVICs, disrupt their ability to maintain mechanical homeostasis, and lead to VHD.